WT1 and leukemia: The findings of this study will contribute to the development of strategies for generating sufficient quantities of WT1 leukemia-specific T cells from healthy donors to augment effective T-cell immunity in leukemia patients and to broaden the applicability of T-cell-based therapies for leukemia.